Know your territory. Surgeon data sized to the states you work, built for independent reps and distributors.
Home Markets Company Account © 2026 MedaRep LLC. Built on CMS Medicare utilisation, Open Payments, PECOS Doctors & Clinicians, NPPES and Census data; not endorsed by CMS.
Internal targeting material; not for use in customer-facing claims.
Rank Markets PricingMarkets › CompareCompare two markets Any covered state and procedure, side by side
Bone graft & orthobiologics
Radiofrequency ablation (facet, genicular, basivertebral) Spinal cord & DRG stimulation Peripheral nerve stimulation & intrathecal pumps
LAA occlusion & loop recorders EP ablation Pacemaker, ICD & CRT implantation
Coronary intervention (PCI) Structural heart (TAVR, TEER) Mechanical circulatory support PFO & septal closure
Peripheral arterial intervention Dialysis access Thrombectomy, IVC filters & venous stents Carotid revascularization Superficial venous ablation Aortic endografts (EVAR/TEVAR)
CSF shunts Aneurysm & intracranial embolization DBS & VNS Stroke thrombectomy
Bariatric surgery Hernia repair Antireflux & hiatal hernia surgery Colorectal resection Cholecystectomy & appendectomy Breast reconstruction
Prostatectomy & nephrectomy Incontinence, prolapse & sacral neuromodulation Kidney stone management BPH procedures Hysterectomy, hysteroscopy & ablation
Sinus surgery & balloon dilation Ear tubes & middle ear surgery Sleep apnea & airway implants Cochlear implants
Cataract & MIGS Vitreoretinal surgery
Colonoscopy & upper endoscopy ERCP & endoscopic ultrasound Bronchoscopy & lung nodule
Breast biopsy & localization Tumor & fibroid embolization Tumor ablation
CGM & insulin pump management
Cholecystectomy & appendectomy · Arkansas Cholecystectomy & appendectomy · Texas Surgeons, 2024 59 216 Medicare fee-for-service cases 2,014 9,832 Growth since 2019 (Medicare FFS) −6.1%/yr −5.4%/yr Forecast cases (Medicare FFS) 1,900 in 2030 10,900 in 2030 Forecast growth −0.9%/yr to 2030 +1.7%/yr to 2030 Per 1,000 Medicare beneficiaries 5.5 4.7 Medicare Advantage share 49% 59% Out of hospital 3% (−2 pts since 2019) 4% (−1 pts since 2019) Cases per surgeon 34 46 Top 10 surgeons' share 25% 11% Surgeons growing 1 11 New since the base year 4 16 Likely to stop billing it 12 by 2026 82 by 2026 Forecast miss, 1 year (procedure) 3% 3% Company payments per surgeon adding up…
Medicare figures: from CMS; growth and the forecast count fee-for-service alone, which falls as patients move to Medicare Advantage, and the all-Medicare and all-payer estimates come with a paid plan . Out of hospital: surgeons’ claims in surgery centers and offices in CMS’s latest claim summary. Payments: consulting, speaking, meals and travel tied to the procedure’s products in the latest Open Payments year, royalties left out. Both rankings, surgeon by surgeon The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.
Company payments per surgeon $154 $1,635